Introduction
============

Plants are a great source of useful phytochemicals, which have inhibitory effects against some microorganisms in vitro and are effective in the treatment of various conditions \[[@B1]\]. Generally, 1-10% of plants (out of approximately 250,000-500,000 species) on earth are used by humans \[[@B2]\]. In recent years, there has been a growing global interest in the use of medicinal plants for disease prevention and treatment, especially in Iran \[[@B3]\]. Limited success in the treatment of human diseases, undesirable side effects of chemical drugs, and growing emergence of drug resistance, particularly to antibiotics, have led to increased use of medicinal plants \[[@B4]\].

Medicinal plants are a widespread source of biologically active compounds including alkaloids, tannins, flavonoids, and phenolic compounds. Accordingly, they are of marked significance to the health of individuals and communities and are widely used for disease treatment \[[@B2]\].

*A. tripedale*belonging to the Liliaceae family*,*is a wild *Allium* species native to the Caucasus (North + South), Iraq, Turkey, and Iran. This plant has longand strong stems (50-90 cm in length) and some what unpleasant taste \[5, 6\]. *A. tripedale* has been extensively used by locals as a spicy vegetable and for the treatment of infections. Given the presence of saponins in the structure of this plant, it is expected to have inhibitory effect against pathogenic fungi \[[@B7]\].

Since the early 1990s, the increase in the number of infections caused by pathogenic and opportunistic fungi has been introduced as the leading cause of mortality among hospitalized patients \[[@B8]\]. In other words, a large number of people are suffering from fungal infections, and these infections are posing a great threat to mankind \[[@B9]\]. In addition, the increased use of antifungal agents has led to the development of resistance to the available drugs.

*Candida albicans* as an opportunistic pathogen plays an important role in the infection and is the most common cause of cutaneous, oral, and systemic diseases in immunodeficiency patients \[10\]. Although *Candida albicans* is still the major species isolated from clinical samples in the majority of individuals,it is well known that some other non*-albicans Candida* spp. such as *Candida glabrata*, *Candida krusei*, *Candida parapsilosis,* and *Candida tropicalis* infections are significantly widespread. Candidiasis associated with this kind of non-*albicans Candida*spp. pose a clinical challenge because they are resistant to common antifungal agents such as fluconazole and amphotericin B \[[@B11], [@B12]\].

Regarding the increase in the use of antifungal agents and resistance to some types of *Candida*spp. and the undesirable side effects of chemical drugs, it is essential to explore new sources of treatment, particulary among herbal plants \[[@B8], [@B13]\]. To the best of our knowledge, no has yet explored the antifungal activity of *A. tripedale*against *Candida*isolates.The purpose of this study was to evaluate chemical composition and antimicrobial activity of hydroalcoholic extract of *A. tripedale*against different *Candida* spp.

Materials and Methods
=====================

***Plant collection***

*Tripedale*was collected from the highlands of Shahrekord in southeast of Iran (Isfahan Province). The collected samples were identified in Ahvaz Agricultural and Natural Research Centre (Herbarium No. A151640100AP). Extraction and laboratory examinations were carried out in Ahvaz University of Medical Sciences, Ahvaz, Iran. The aerial parts of the plants were aired indoors at room temperature and then finely powdered using an electric grinder (Busch, MKM6003, Slovenia). It took two days to extract 20 g of plant materials by soxhlet with 120 ml ethanol 80%. The extract was filtered using Whatman qualitative filter paper, Grade 1. The extract was preserved in sterilized airtight bottles at 4ºC, and then to prepare the dried extracts, the solution was placed in a bain-marie at 40ºC for 24 h prior to use \[[@B14]\].

***Gas chromatography and mass spectroscopy (GC-MS) analysis***

GC-MS analysis of ethanolic extract of the whole *A. tripedale* was performed on GC 7890A equipped with MS 5975C detector and HP-5ms capillary column (30 × 0.25 m, 0.25 µm; Agilent Co., USA). The initial column temperature was set at 60ºC, then increased from 60ºC to 190ºC (heating rate: 5ºC per minute), from 190ºC to 270ºC for 30 min, and finally kept at 270ºC for approximately 5 min; the total analysis time was about 34 min.

***Compound identification***

Interpretation of GC-MS was performed via the National Institute Standard and Technology (NIST) database. The spectra of the unknown components were compared with those of the known ones registered in the NIST library. The name, molecular weight, and structure of the components of the test materials were determined.

***Preparation of organisms***

Standard strains of *C. albicans*(ATCC 3153), *C. parapsilosis* (ATCC 2195), and *C. krusei* (ATCC 573) were obtained from the Department of Mycology, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran. The strains were cultured on Sabouraud Dextrose Agar (SDA) (Merck, Germany) medium. Fungal suspension was prepared with concentration adjusted to 1.5~˟~10^6^ CFU/ml in sterile distilled water as described by Forbes et al. \[[@B15]\].

***Well diffusion assay***

Agar well diffusion method is extensively used to evaluate the antimicrobial activity of plants or microbial extracts. To determine the effective concentration, inhibition zones of hydroalcoholic extract of *A.tripedale* were examined against *C.albicans* (ATCC 3153), *C. parapsilosis* (ATCC 2195), and *C. krusei* (ATCC 573) strains by using well assay technique. The agar plate surface was inoculated overnight by spreading inoculum of *Candida* spp. over the entire SDA surface. A hole 6 to 8 mm in diameter was punched with a sterile tip. Then, the extract was added to the pits in the agar medium and incubated under suitable conditions at 27°C for 24 h \[[@B16]\]. The diameter of the inhibitory zone was measured, and the corresponding effective concentration was chosen for subsequent experiments \[[@B17]\].

***Disk diffusion method***

The fungal broth culture aliquots were added to SDA. Sterile paper disks (Merck, Germany) were impregnated with 50 μl of extract solution and placed on the culture plates. The plates were incubated at 37°C for 24 h. Antifungal activity was evaluated by measuring the inhibition zone diameter \[[@B18]\]. Fluconazole was used as positive control \[[@B19]\], whereas paper disks loaded with solvents (ethanol and distilled water) were used as negative controls.

***Statistical analysis***

Statistical analysis was performed using SPSS, version 10.0. The inhibition diameters of the test substances were expressed as mean and standard deviation. Group comparisons were performed using One-way analysis of variance (ANOVA) followed by Waller-Duncan Post Hoc test. *P-value* less than 0.05 was considered statistically significant.

Results
=======

***The phytochemical analysis***

The phytocomponents present in the hydroalcoholic extract of *A. tripedale*were identified by GC-MS analysis; GC-MS running time is 34 min. The active compounds in the hydroalcoholic extract of the plant, their retention time (RT), molecular formula, and molecular weight are provided in [Table 1](#T1){ref-type="table"}, and GC-MS chromatograms are presented in [Figure 1](#F1){ref-type="fig"}.

The gas chromatogram is used to help identify a mixture of compounds by separating compounds according to each compound\'s retention time. The heights of the peaks indicate the relative concentrations of the components present in the plant. GC-MS analysis revealed the presence of 40 compounds by dichloromethane solvent; the major compounds included tetracosane, hexadecanoic acid, 1-eicosanol, 1,2-dihydro-pyrido\[3,2,1-kl\]phenothiazin-3-one, 2-hexadecen-1-ol, and 3,7,11,15-tetramethyl.

***Disk and well diffusion assay***

Preliminary screening of the antifungal activity of hydroalcoholic extracts of *A. tripedale* was performed against *Candida* spp. using the disk and well diffusion assay. The results showed variation in the antifungal properties of hydroalcoholic extract of *A. tripedale* ([Table 2](#T2){ref-type="table"}). The extract showed strong activity (inhibition zone ⩾ 20 mm), moderate activity (inhibition zone \< 12-20 mm), and no inhibition (zone \< 12 mm). Fluconazole, a known antifungal antibiotic, as a positive control significantly inhibited the growth of *Candida*spp*.*([Figure 2](#F2){ref-type="fig"}). Based on the available evidence, the major effective antifungal activity by the hydroa-lcoholic extract was achieved against *C. albicans*([Figure 3](#F3){ref-type="fig"}). The hydroalcoholic extract of *A. tripedale*inhibited the growth of *C. parapsilosis* by well diffusion assay and *C. krusei* by disk diffusion assay in a dose-dependent manner ([Figures 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}).

###### 

Phytocomponents identified in the hydroalcoholic extract of *A. tripedale* by gas chromatography and mass spectroscopy

  **S.NO.**   **ID**                                                             **RT**   **Area%**   **CAS**          **Molecular formula**      **Molecular weight g/mol**
  ----------- ------------------------------------------------------------------ -------- ----------- ---------------- -------------------------- ----------------------------
  1           2-Pentene, 2-methyl                                                3.133    0.2         625-27-4         CH~3~CH~2~CH=C(CH~3~)~2~   84.16
  2           Furan, 2,4-dimethyl-                                               7.624    0.18        3710-43-8        C~6~H~8~O                  96.1271
  3           Ethane, 1,1,2,2-tetrachloro-                                       9.324    0.72        79-34-5          C~2~H~2~Cl~4~              167.8493
  4           Benzaldehyde                                                       11.435   0.19        100-52-7         C~7~H~6~O                  106.1219
  5           2,4 HEPTADIENAL                                                    11.801   1.70        4313-03-5        C~7~H~10~O                 110.1537
  6           Nonanal                                                            13.924   0.5         124-19-6         C~9~H~18~O                 142.2386
  7           Benzeneacetaldehyde                                                14.193   0.42        122-78-1         C~8~H~8~O                  120.1485
  8           2-Fluorophenylhydrazine                                            14.908   0.13        2368-80-1        C~6~H~7~FN~2~              126.1316
  9           Octanoic Acid                                                      15.441   0.35        124-07-2         C~16~H~30~O~4~Sn           405.117
  10          Benzoic acid                                                       1.654    0.24        65-85-0          C~7~H~6~O~2~               122.1224
  11          Pyridine, 3-(phenylazo)-                                           17.581   0.18        2569-55-3        C~11~H~9~N~3~              183.21
  12          4-Pyridinamine, N-methyl-N,3-dinitro-                              18.73    0.14        104503-82-4      C~6~H~6~N~4~O~4~           198.13624
  13          3-Methyl-2,3-dihydro-benzofuran                                    18.347   0.34        13524-73-7       C~9~H~10~O                 134.1751
  14          1-Carboxymethyl-2(1H)-pyridone                                     19.440   0.29        56546-36-2       C~7~H~7~NO~3~              153.1354
  15          .alpha.-(Aminomethylene)glutaconicanhydride                        20.12    0.15        67598-07-6       C~6~H~5~NO~3~              139.1088
  16          2,4-Decadienal                                                     20.093   0.43        2363-88-4        C~10~H~16~O                152.23344
  17          2-Bromo-5-(hydroxymethyl)pyridine                                  20.178   0.12        122306-01-8      C~6~H~6~BrNO               188.02194
  18          (E,Z,Z)-2,4,7-Tridecatrienal                                       20.310   0.67        1000314-35-6     C~13~H~20~O                192.3016
  19          Hexadecane, 7,9-dimethyl-                                          20.836   0.74        21164-95-4       C18 H38                    254.50
  20          2,4-Decadienal                                                     20.934   0.64        2363-88-4        C~10~H~16~O                152.2334
  21          2-Methoxy-4-vinylphenol                                            21.763   0.6         7786-61-0        C~9~H~10~O~2~              150.1745
  22          2-Propenoic acid, 3-phenyl-                                        24.910   0.41        621-82-9         C~9~H~8~O~2~               148.1586
  23          2(4H)-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, (R)-   28.687   0.25        17092-92-1       C~11~H~16~O~2~             180.24
  24          Tetradecanal                                                       29.265   0.26        124-25-4         C~11~H~20~O~2~             184.2753
  25          1,1-Difluoro-2-methyl-3-ethyl cyclopropane                         30.032   0.22        1000144-82-1     C6H10F2                    120.140406
  26          Cyclodecane                                                        30.140   0.19        293-96-9         C10H20                     140.27
  27          Tetradecanoic acid                                                 30.243   0.65        544-63-8         C~14~H~28~O~2~             228.37
  28          2-Hexadecen-1-ol, 3,7,11,15-tetramethyl-, \[R-\[R\*,R\*-(E)\]\]-   30.306   4.67        150-86-7         C~20~H~40~O                296.531
  29          Methyl .beta.-d-galactopyranoside                                  30.524   0.48        1000126-04-6     C~7~H~14~O~6~              194.18246
  30          3-Pyridinamine, N-methyl-2-nitro-                                  30.655   0.15        32605-06-4       C~6~H~7~N~3~O~2~           153.1387
  31          2-Pentadecanone, 6,10,14-trimethy                                  31.565   0.85        502-69-2         C~18~H~36~O                268.4778
  32          Hexadecanoic acid                                                  340380   6.91        57-10-3          C~16~H~32~O~2~             256.42
  33          Phthalic acid, butyl undecyl ester                                 34529    0.92        1000308-91-2     C~23~H~36~O~4~             376.52954
  34          Hexadecanoic acid, ethyl ester                                     34.586   0.41        628-97-7         C~18~H~36~O~2~             284.47724
  35          Phthalic acid, propyl nonyl ester                                  36.641   0.41        1000309---06-4   C~20~H~30~O~4~             334.4498
  36          Cyclohexanol, 1-methyl-4-(1-methylethyl)-                          36.829   0.89        21129-27-1       C10H20O                    156.27
  37          Phthalic acid, isobutyl pent-2-en-4-yn-1-yl ester                  45.761   1.56        1000315-45-6     C~17~H~18~O~4~             286.32242
  38          1-Eicosanol                                                        49.338   6.79        629-96-9         C~20~H~42~O                298.54688
  39          Tetracosane                                                        50.751   34.17       646-31-1         C~24~H~50~                 338.6538
  40          1,2-Dihydropyrido(3,2,1-kl)phenothiazin-3-one                      54.236   4.94        69513-42-4       C~15~H~11~NOS              253.31894

![Gas chromatography and mass spectroscopy chromatogram of hydroalcoholic extract of *A. tripedale*](cmm-3-006-g001){#F1}

###### 

Antifungal activity of the *A. tripedale* in disk and well diffusion assay

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Zone of inhibition (mm)**   **Extract concentration**\                                                                                                      
                                **(mg/mL)**                                                                                                                     
  ----------------------------- ---------------------------- ---------- --------- --------- --------- ---- ---- ---------- --------- --------- --------- ------ -------------------------
  \-                            \-                           10±.0.25   17±0.11   28±0.34   28±0.28   \-   \-   10 ±0.28   30±0.17   10± 0.0   21±0.17   50     Hydro-alcoholic extract

  \-                            \-                           \-         5±.0.28   19±1.04   20±0.11   \-   \-   \-         21±0.57   \-        6±0.36    25     

  \-                            \-                           \-         5±.0.28   10±0.28   18±0.0    \-   \-   \-         22±28     \-        3±.28     12.5   

  \-                            \-                           \-         \-        \-        \-        \-   \-   \-         19±0.20   \-        \-        6.25   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![Anti-fungal activity of fluconazole (50 mg/ml) against *C. albicans* by disc (A) and well (B) diffusion assay after 48 h](cmm-3-006-g002){#F2}

![Anti-fungal activity of hydroalcoholic extract of *A. tripedale* (50 mg/ml) against *C. albicans* by disc (A) and well (B) diffusion assay after 48 h](cmm-3-006-g003){#F3}

![Anti-fungal activity of hydroalcoholic extract of *A. tripedale* (50 mg/ml) against *C. parapsilosis* well diffusion assay after 48 h](cmm-3-006-g004){#F4}

![Anti-fungal activity of hydroalcoholic extract of *A. tripedale* (50 mg/ml) against *C. krusei* by well diffusion assay after 48 h](cmm-3-006-g005){#F5}

Discussion
==========

Evidence suggests that fungal infections annually affect more than a billion people, and this rate is ever increasing. *Candida* spp. can be systemic or infect different parts of the body such as skin, nails, respiratory tract, urogenital system, and alimentary canal \[[@B20]\]. Although several species of *Candida* are potentially pathogenic in humans, *Candida albicans* is the most important cause of severe candidiasis \[[@B21]\]. Trizoles initially appear to be highly effective against fungal infections, but nowadays, increased resistance is being reported and azole resistant has instigated extensive research to evaluate the effect of antifungal agents from different sources, especially medicinal plants \[[@B19]\]. The most famous antifungal medicinal plants belong to Liliaceae family, where more reports are found on antifungal activity of *Allium* genus \[[@B22]\]. The antifungal properties of the *Allium* genus were mentioned in some studies. Shams-Ghahfarokhi et al. (2007) reported that aqueous extracts of *Allium cepa*and*Allium sativum* had antifungal activity against *Malassezia furfur, Candida*spp. and several strains of various dermatophyte species in a dose-dependent manner with the maximum of 100% at defined concentrations \[[@B23]\]. Another study by Amin and Kapadnis proved the antifungal activity of *Allium ascalonicum* against 23 fungal strains \[[@B24]\].

In this study, we examined the antifungal effect of hydroalcoholic extract of *A. tripedale* against different strains of *Candida* by disk and well diffusion assay. Our results revealed that the hydroalcoholic extract (50 mg/ml) had the greatest effect on *C. albicans*. However, it also had inhibitory effect against *C. parapsilosis* and *C. krusei*.

Based on the analysis conducted on the hydroalcoholic extract components using GC-MS method, 40 compounds were identified in this plant that had different properties. We found that tetracosane and other higher alkenes had antioxidant, antitumor, and antifungal properties, particularly against fungal spores and germination \[[@B25]\]. Tetradecanoic acid and eicosane had antioxidant and antimicrobial activities \[[@B26]\]. Hexadecanoic acid is known to have antioxidant and hypocholesterolemic properties and is a constituent of nematicides, pesticides, lubricants, antiandrogens, flavoring agents, hemolytics 5-alpha reductase inhibitors, antifeedants, and insect-repellents \[[@B27]\].

Benzoic acid derivatives possess antibacterial and antifungal properties. Phenazopyridine hydrochloride is a topical analgesic that relieves the irritative symptoms associated with urinary tract infection through acting on the mucosal lining of the urinary tract. This agent is compatible with antibiotics and relieves pain before the antibiotic begins to control the infection. Propionic acid is an important chemical commonly used as a raw material in different industries \[[@B28]\]. Propionic acid, the biopreservative produced by *Propionibacterium*spp., is capable of inhibiting the growth of molds, bacteria, and dairy-spoilage yeasts such as *Zygosaccharomyces bailii*and *Candida*spp. \[[@B29]\]. Phenolic compounds, esters, alkanes, aldehydes, alkenes, and ketones are the major volatile compounds, which have anti-inflammatory, antiarthritic, antidiabetic, antiulcer, hypolipidemic, antiatherosclerotic, anti-HIV, and cytotoxic activities \[[@B30]\]. Based on the results of the present study, hydroalcoholic extract of *A. tripedale*had a significant inhibitory effect against the growth of various strains of *Candida*. In sum, it seems that *A. tripedale* is a major source of anti-fungal compounds, which can be applied for the treatment of infectious diseases.

Conclusion
==========

This is the first report on the GC-MS analysis of *A. tripedale*. It can be concluded that *A. tripedale*contains various important bioactive compounds. Therefore, it is recommended as a plant of phytochemical and pharmaceutical importance. Further studies are required to isolate the active ingredients of the extract and elucidate its mechanism of action in various diseases.
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